We are live on ! Find out more
WA

Wambolt & Associates Portfolio holdings

AUM $297M
1-Year Est. Return 17.23%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+17.23%
3 Year Est. Return
+62.24%
5 Year Est. Return
+110.77%
10 Year Est. Return
AUM
$344M
AUM Growth
+$9.99M
Cap. Flow
+$1.84M
Cap. Flow %
0.53%
Top 10 Hldgs %
27.03%
Holding
223
New
4
Increased
92
Reduced
89
Closed
20

Top Sells

Rank Stock Value
1
BHP icon
BHP
BHP
+$2.84M
2
MDT icon
Medtronic
MDT
+$2.74M
3
BCE icon
BCE
BCE
+$1.83M
4
DEO icon
Diageo
DEO
+$1.71M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$446K

Sector Composition

Rank Sector Weight
1 Technology 22.21%
2 Financials 17.92%
3 Consumer Staples 8.45%
4 Industrials 7.89%
5 Healthcare 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPRT icon
126
Copart
CPRT
$27B
$494K 0.14%
9,260
MET icon
127
MetLife
MET
$61.9B
$491K 0.14%
7,030
-217
-3% -$15.5K
SPSM icon
128
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.1B
$485K 0.14%
11,789
+19
+0.2% +$792
EMR icon
129
Emerson Electric
EMR
$83.9B
$477K 0.14%
4,419
-181
-4% -$20K
RPV icon
130
Invesco S&P 500 Pure Value ETF
RPV
$1.65B
$473K 0.14%
5,710
-624
-10% -$52.9K
IVV icon
131
iShares Core S&P 500 ETF
IVV
$878B
$471K 0.14%
858
-7
-0.8% -$3.68K
MRK icon
132
Merck
MRK
$322B
$470K 0.14%
3,672
-190
-5% -$24.5K
NSSC icon
133
Napco Security Technologies
NSSC
$1.32B
$454K 0.13%
8,654
-165
-2% -$7.55K
BR icon
134
Broadridge
BR
$17.8B
$441K 0.13%
2,245
-561
-20% -$111K
WSM icon
135
Williams-Sonoma
WSM
$26.9B
$434K 0.13%
3,134
ISRG icon
136
Intuitive Surgical
ISRG
$127B
$431K 0.13%
987
-90
-8% -$35.8K
IDOG icon
137
ALPS International Sector Dividend Dogs ETF
IDOG
$551M
$425K 0.12%
14,201
-8,653
-38% -$262K
VBK icon
138
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
$424K 0.12%
1,710
-347
-17% -$86.6K
SLYV icon
139
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.89B
$424K 0.12%
5,473
-328
-6% -$26K
PFE icon
140
Pfizer
PFE
$143B
$421K 0.12%
14,916
-3,789
-20% -$104K
FISV
141
Fiserv Inc
FISV
$28.8B
$419K 0.12%
2,845
-53
-2% -$8.02K
INDA icon
142
iShares MSCI India ETF
INDA
$6.89B
$407K 0.12%
7,241
-1,607
-18% -$85.1K
PAYX icon
143
Paychex
PAYX
$41.6B
$394K 0.11%
3,370
-509
-13% -$62.2K
ADSK icon
144
Autodesk
ADSK
$49.5B
$390K 0.11%
1,587
+41
+3% +$9.21K
CL icon
145
Colgate-Palmolive
CL
$73.1B
$390K 0.11%
4,083
-115
-3% -$10.6K
SPLV icon
146
Invesco S&P 500 Low Volatility ETF
SPLV
$7.12B
$382K 0.11%
5,910
-2,251
-28% -$146K
GS icon
147
Goldman Sachs
GS
$300B
$379K 0.11%
818
+70
+9% +$30.7K
MKL icon
148
Markel Group
MKL
$23.3B
$378K 0.11%
240
DUK icon
149
Duke Energy
DUK
$97.8B
$368K 0.11%
3,705
-1,481
-29% -$148K
TIP icon
150
iShares TIPS Bond ETF
TIP
$14.5B
$364K 0.11%
3,438
-349
-9% -$37.1K

Similar funds

Wambolt & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Wambolt & Associates held 223 positions worth $344M, up 3% from $334M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Wambolt & Associates's Q2 2024 filing shows 4 new, 92 increased, 89 reduced and 20 closed positions. Its largest new stake was Idexx Laboratories: 421 shares worth $201K. The largest sale was BHP, an estimated $2.84M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Staples.

  • Wambolt & Associates's largest Q2 2024 buy was Idexx Laboratories: 421 shares worth $201K.
  • Wambolt & Associates added most to Schwab Fundamental International Large Company Index ETF in Q2 2024, an estimated $3.21M increase.
  • Wambolt & Associates's biggest Q2 2024 reduction was ALPS International Sector Dividend Dogs ETF, cutting an estimated $262K.
  • Wambolt & Associates fully exited BHP in Q2 2024, selling an estimated $2.84M.
  • Wambolt & Associates's ten largest holdings make up 27% of its $344M portfolio in Q2 2024.
  • Wambolt & Associates opened 4 new positions and closed 20 in Q2 2024.
  • Wambolt & Associates's portfolio value rose 3% quarter-over-quarter to $344M.

Based on Wambolt & Associates's 13F filing for Q2 2024, filed 8 Aug 2024.